Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Cytokinetics Inc Transaction History

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.

$721 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 07, 2024	BUY	$63.75 - $108.06 $7.43 Million - $12.6 Million	116,534 Added 33.83%	461,018 $32.3 Billion
Q4 2023 Apr 10, 2024	BUY	$26.88 - $83.49 $9.26 Million - $28.8 Million	344,484 New	344,484 $28.8 Billion

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$720 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$577 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$476 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$382 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$317 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.

Account